VIR Biotechnology
vir.bioNasdaq: VIR
VIR Biotechnology works in biotech and pharma and is based in San Francisco, CA. It was founded in 2016, has about 367 employees, and trades on Nasdaq as VIR.
Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond.
Source: the company's website
Lately at VIR Biotechnology
Who do you want to reach at VIR Biotechnology?
VIR Biotechnology has about 367 employees. Pick a team, and Rocketship searches for them live when you look. You see who it finds once you sign up. This page never lists anyone by name.
Counts from Rocketship’s people data, checked Nov 19, 2026
Each team opens its decision makers in Rocketship, the same people counted here.
Why reach VIR Biotechnology now
What changed lately, read from public records. Every number links to its source.
Hiring
19
open jobs
5 of them were posted in the last 30 days. Operations has 10 of them (53%).
new: posted in the last 30 daysopen longerPress a team to see its decision makers with Rocketship.
Newest openings
- Senior Director, Commercial Supply Chain (Temporary)Nov 19
- Associate Director, CMC Project Management (Temporary)Nov 13
- Senior Human Resources Business Partner (Temporary)Nov 4
Source: VIR Biotechnology's Greenhouse job board, checked November 21, 2026
Your browser asks Greenhouse directly. Rocketship is not in between.
Revenue
−8%
revenue change in FY2025
Revenue
$74 million in FY2024 to $69 million in FY2025, from the annual report (10-K).
Source: SEC EDGAR, checked November 19, 2026
Budget timing
Dec 31
fiscal year end
Budget timing
Teams usually set next year's budgets in the months before the year ends.
Source: SEC EDGAR, checked November 17, 2026
Your way in at VIR Biotechnology
Type what you sell. The page names the team that usually buys it here, what that team is doing now, and how many of its people Rocketship knows.
Matched on the word “freight”. A word list on this page picks the team. No AI reads what you type, and nothing leaves the page until you press the button.
Who usually buys “freight shipping” at VIR Biotechnology
The operations team
- Open jobs
- 104 new in 30 days, on their job board
- Rocketship knows
- about 30people on this team
- Decision makers here
- Searched liveRocketship looks when you press the button
Titles the button searches: Chief Operating Officer, VP of Operations, Head of Operations, Director of Operations.
Newest opening on this team: Senior Director, Commercial Supply Chain (Temporary), posted Nov 19.
Their inbox: mail passes Proofpoint first, so keep the first email plain text. How their email works
7-day free trial on every monthly plan. Card required.
Before you email VIR Biotechnology
Read from vir.bio's public DNS records on November 21, 2026. Anyone can check them; the records are at the end of this section.
Where mail lands first
Proofpoint
A mail filter: it checks every message before any inbox sees it. Behind it, the inboxes are on Microsoft 365 (named in the SPF record).
What it means for you
Every message to VIR Biotechnology passes Proofpoint before it reaches an inbox. A filter like this opens links and can load images to test them, so an open or a click from VIR Biotechnology does not mean a person read your email.
- Plain text, no attachment, and no more than one link.
- Judge interest by replies, not by opens or clicks.
- A few emails a day from a real inbox, not a burst from a new domain.
Rocketship writes in your voice, sends from your own Gmail and follows up on its own.
How do I send cold email without landing in spam?Why do my emails go to spam?
Allowed to send as vir.bio
- Microsoft 365
Domain lock (DMARC)
Set to reject
Mail that pretends to come from this domain is refused. Reject is the strictest DMARC setting. This is about mail sent as vir.bio, not mail sent to it.
Verified with
- DocuSign
- Apple
- Smartsheet
- Microsoft
- Miro
- Atlassian
Each service asked the domain to add a DNS record as proof of ownership. A record can stay after a service is dropped, and security tools are left off this list.
See the records this section reads
- MX
- mxa-0075d101.gslb.pphosted.commxb-0075d101.gslb.pphosted.com
- SPF
- v=spf1 ip4:54.240.43.16 ip4:72.15.254.252 include:spf.protection.outlook.com a:dispatch-us.ppe-hosted.com include:spf-0075d101.pphosted.com -all
- DMARC
- v=DMARC1; p=reject; sp=none
Check them yourself: nslookup -type=mx vir.bio, nslookup -type=txt vir.bio, nslookup -type=txt _dmarc.vir.bio
Your browser asks Google Public DNS directly. Rocketship is not in between.
How Rocketship would reach VIR Biotechnology
- Step 1
Finds the right people
You say who you want to reach. Rocketship finds them by title and researches each one before anything is written.
- Step 2
Emails them from your own Gmail
It writes in your voice, sends from your inbox and follows up on its own.
- Step 3
Books the meeting
When someone says yes, it offers times from your calendar and puts the meeting on it.
Questions about VIR Biotechnology
How many people work at VIR Biotechnology?
About 367, which puts VIR Biotechnology in the 201 to 500 employee band. The number is from its annual report (10-K) to the SEC for the year ended December 31, 2025.
Where is VIR Biotechnology headquartered?
VIR Biotechnology is headquartered in San Francisco, CA. Source: SEC EDGAR.
When was VIR Biotechnology founded?
VIR Biotechnology was founded in 2016. Source: Wikidata.
Is VIR Biotechnology a public company?
Yes. It is listed on Nasdaq as VIR and files annual reports with the SEC.
What is VIR Biotechnology's revenue?
$69 million for the fiscal year ended December 31, 2025. Source: SEC EDGAR.
What industry is VIR Biotechnology in?
VIR Biotechnology is in biotech and pharma. Source: Wikidata and the SEC's industry code.
Companies like VIR Biotechnology
Same industry: biotech and pharma
Find the decision makers at VIR Biotechnology
Rocketship finds them by title, researches them, emails them from your own Gmail, follows up and books the meeting.
7-day free trial on every monthly plan. Card required.
Facts on this page come from the company's website, Wikidata, and SEC EDGAR, as they stood on November 17, 2026. Wikidata is CC0; SEC filings are public domain; the website is the company's own public home page. The logo is the company’s own, taken from its website, and belongs to its owner. No people are listed. VIR Biotechnology is a trademark of its owner. This page is not made or endorsed by VIR Biotechnology.






